U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07266584) titled 'Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration' on Nov. 19.
Brief Summary: The objective of this study is to evaluate the efficacy and safety of the PRIMA Products in participants with inherited retinal degeneration affecting the macula (including but not limited to Stargardt disease, and Retinitis Pigmentosa).
Eligible participants will be implanted with the PRIMA Stim implant. The participants will be assessed with various visual function and functional vision tests at defined timepoints throughout the clinical investigation with the PRIMA Products. The purpose of this study is to gather enoug...